ClinicalTrials.Veeva

Menu

Virtual World Health Behavior Counseling for Patients With Diabetes

Boston Medical Center (BMC) logo

Boston Medical Center (BMC)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Type 2 Diabetes

Treatments

Behavioral: face to face
Behavioral: virtual world

Study type

Interventional

Funder types

Other

Identifiers

NCT01340079
1RC1LM010412-01

Details and patient eligibility

About

Comparison of 2 methods of delivery health education for African-American women with Type 2 Diabetes. The two methods are: face to face education in small groups, as compared to delivering the same curriculum in the virtual world, Second Life.

Full description

This study will provide health education to African-American women with type 2 diabetes either face to face, or using the Internet. The study seeks to determine how feasible the internet method is for this type of health education, and how it compares to the face to face method. Patients will be recruited from Boston Medical Center. They will do baseline surveys and have blood drawn. They will then be randomized into receiving their diabetes education in a face to face group at BMC, or receiving it online while at home. The online group will receive a computer to access the Internet program and Internet access. Both groups will participate in 8 diabetes education groups, and 4 individual counseling sessions. Subjects will complete surveys before and after the study to measure changes in physical activity, diet, and use of medications, and will have blood tests drawn at BMC before and after the study to measure changes in diabetes control, cholesterol. They will also have blood pressure measured before and after the study period.

Enrollment

89 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosed with T2DM
  2. HbA1c level >= 8.0
  3. Currently treated with diet, oral hypoglycemics or insulin. If currently on insulin, must have a history of prior therapy with diet alone or oral hypoglycemic agents
  4. African-American origin
  5. >= 18 years old
  6. Telephone in home or easy access to one
  7. Able to understand and participate in the study protocol
  8. Functionally capable of meeting the activity goals
  9. Understands and can provide informed consent
  10. Physician approval to participate in the study.

Exclusion criteria

  1. History of diabetic ketoacidosis
  2. Gestational diabetes
  3. Unable or unwilling to provide informed consent
  4. Plans to move out of the area within the 12-month study period
  5. Required intermittent glucocorticoid therapy within the past 3 months
  6. Experienced an acute coronary event (myocardial infarction or unstable angina) within the previous 6 months
  7. Has a medical condition that precludes adherence to study dietary recommendations (e.g., Crohn's disease, ulcerative colitis, end-stage renal disease)
  8. Has a medical or psychiatric illness (i.e., dementia, psychiatric hospitalization or suicidality within past 5 years or takes an neuroleptic medication). We will not exclude based on history of depression or anxiety or taking anti-depressants or anti-anxiety medications.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

89 participants in 2 patient groups

Virtual world
Experimental group
Description:
Virtual world delivery method
Treatment:
Behavioral: virtual world
face to face
Active Comparator group
Description:
face to face method of health education
Treatment:
Behavioral: face to face

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems